Health Care/Hospital

Winner Medical Group Reports Fourth Quarter and Year End Fiscal 2006 Results

SHENZHEN CITY, China, Dec. 20 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported financial results for the fourth quarter and fiscal year ended September 30, 2006. Revenues for the fourth fiscal quarter were $16.64 million compared to $18.56 mil...

2006-12-20 05:01 908

BioVision 2007, the World Life Sciences Forum, Set to Tackle Some of Today’s Most Critical Health, Nutrition and Environmental Issues

-- The 5th edition of BioVision (March 11 - 14, 2007 in Lyon, France) will gather leading international experts on health, nutrition and environment issues to discuss, debate and agree actions for change. LYON, France, Dec. 20 /Xinhua-PRNewswire/ -- BioVision today confirmed its broad...

2006-12-20 18:52 890

MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With BioWa

- Initial Focus on Monoclonal Antibody Targeting IL-5 Receptor in Phase 1 Trials with Asthma Patients - GAITHERSBURG, Md. and PRINCETON, N.J., Dec. 19 /Xinhua-PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI) and BioWa, Inc. announced today that they have entered into a licensing and coll...

2006-12-19 19:00 1010

The Prestigious Scientific Journal Nature Recognizes the Scientific Work Carried out With the Research Centre of Hospital Laval and at the University Laval

Measuring waist circumference is key to assessing cardiometabolic risk QUEBEC, Dec. 15 /Xinhua-PRNewswire/ -- Today's issue of Nature (Vol # 444) summarizes in an article, signed by both Professor Jean-Pierre Despres and Doctor Isabelle Lemieux from the University of Laval, the current ...

2006-12-15 11:25 974

Landmark Study of Avastin in Lung Cancer Published Today in New England Journal of Medicine

- Avastin is First Medicine to Extend Survival Beyond One Year in Patients with Previously Untreated Non-Small Cell Lung Cancer BASEL, Switzerland, Dec. 14 /Xinhua-PRNewswire/ -- Avastin is the first medicine proven to help previously untreated patients suffering from the most common ...

2006-12-14 09:38 854

New VaccineS Against Cervical Cancer Major Opportunity for Developing World

LONDON and GENEVA, Dec. 13 /Xinhua-PRNewswire/ -- The introduction of new vaccines against Human Papillomavirus (HPV), the virus that causes cervical cancer, could have a major impact on the health of women in the developing world. More than 250 000 women died from cervical cancer in 2005...

2006-12-13 17:08 957

China Sky One Medical Purchases Competitor Heilongjiang Tianlong Pharmaceutical Company

LOS ANGELES, Calif., Dec. 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicines in China, has announced that a strategic agreement was reached between Liu Yan-qing, pres...

2006-12-13 21:30 1102

New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke

- The PREVAIL Study Showed That in Acute Ischemic Stroke Patients Treated With Clexane(R) / Lovenox(R), the Risk of Having a VTE was Lowered by a Significant 43% With no Significant Increase in Clinically Important Bleedings When Compared to UFH ORLANDO,...

2006-12-13 09:47 1104

Xeloda Meets Primary Endpoint in Multinational Phase III Advanced Colorectal Cancer Study

- Roche to Approach World-Wide Regulatory Authorities for a New File Submission BASEL, Switzerland, Dec. 11 /Xinhua-PRNewswire/ -- Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its pri...

2006-12-11 14:30 893

Data Presented to FDA Panel Show TAXUS(TM) Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures

PARIS, Dec. 11 /Xinhua-PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) yesterday presented data on its long-term randomized clinical trials to a special U.S. Food and Drug Administration (FDA) panel, showing that the TAXUS(TM) paclitaxel-eluting coronary stent is as safe as bare-m...

2006-12-11 09:38 854

The International Myeloma Foundation: Multiple Studies at Global Cancer Conference Show New Therapies Changing the Outlook for Patients With Blood Cancers

- Studies Presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) ORLANDO, Fla., and NORTH HOLLYWOOD, Calif., Dec. 8 /Xinhua-PRNewswire/ -- The International Myeloma Foundation (IMF) -- conducting research and providing education, advocacy and support for mye...

2006-12-08 22:00 1090

A New Gold Standard in Early Breast Cancer as Arimidex(TM) (Anastrozole) Overtakes Tamoxifen

-- More Patients Set to Benefit as Weight of Evidence for 'Arimidex' Prompts Wave of Change MACCLESFIELD, England, Dec. 7 /Xinhua-PRNewswire/ -- Today, for the first time in over 20 years, a new gold standard treatment has emerged for postmenopausal women with early breast cancer. I...

2006-12-07 19:33 1053

WuXi PharmaTech Announces Expanded Agreement with Merck & Co., Inc.

SHANGHAI, China, Dec. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech Co. Ltd., China’s leading pharmaceutical R&D service company, announced today that Merck & Co., Inc., of Whitehouse Station, NJ, USA, has agreed to extend and expand an agreement through which WuXi provides a variety of chemist...

2006-12-07 21:00 1345

SAMHSA and Ad Council Unveil National Mental Health Anti-Stigma Campaign - Video Available

Only One in Four Americans Believes People are Sympathetic Towards Those With Mental Illnesses WASHINGTON, Dec. 4 /PRNewswire/ -- The Substance Abuse and Mental Health Services Administration (SAMHSA), in partnership with the Ad Council, today launched a national awareness public service ...

2006-12-05 13:48 1252

Global Strategy Aims For Effective Malaria Vaccine By 2025

BANGKOK, Thailand, Dec. 5 /Xinhua-PRNewswire/ -- A report by the world’s leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine. The Malaria Vaccine Technology Roadmap, a new global s...

2006-12-05 11:54 878

China Medicine Reports Third Quarter Results

GUANGZHOU, China, Dec. 4 /PRNewswire-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME), a leading distributor of medical products, traditional pharmaceutical and Chinese medicines, herbs and dietary supplements today is reporting third quarter financial results for the pe...

2006-12-04 22:00 786

The Research and Development Center of Harbin First Bio-Engineering Co., Ltd., a Wholly Owned Subsidiary of China Sky One Medical, Inc. (OTC Bulletin Board: CSKI) is Named as key Provincial Laboratory by Heilongjiang Provincial Science and Technology Department

LOS ANGELES, Dec. 4 /Xinhua-PRNewswire/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI) has been notified that at an accreditation meeting on November 21, the research and development center of Harbin First Bio- engineering Co., Ltd., a wholly owned subsidiary of China Sky One, wa...

2006-12-04 21:30 1480

Cathay Industrial Biotech Completes US$52 Million Series B Financing

SHANGHAI, China, Dec. 4 /Xinhua-PRNewswire/ -- Cathay Industrial Biotech Ltd. (CIB) today announced the closing of its US$52 million Series B financing. Together with the US$26 million Series A financing in May 2006, CIB has raised a total of US$78 million in 2006. Series B Invest...

2006-12-04 21:00 1124

Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs

-- New Results From the Only Large European Study Combining Blood Pressure-Lowering With Cholesterol Reduction in Patients With Moderate Cardiac Risk Prevents Half of Heart Attacks LONDON, Dec. 4 /Xinhua-PRNewswire/ -- The risk of heart attack can be reduced by more t...

2006-12-04 16:01 1070

WORLD AIDS DAY MESSAGE

GENEVA, Dec. 1 /Xinhua-PRNewswire/ -- The HIV/AIDS epidemic continues to grow. Some 40 million people, their families, and their communities, are now living with HIV. Effectively tackling this epidemic remains one of the world’s most pressing public health challenges. (Logo: http...

2006-12-01 17:24 919